US20180193238A1 - Beauty care method - Google Patents
Beauty care method Download PDFInfo
- Publication number
- US20180193238A1 US20180193238A1 US15/106,933 US201415106933A US2018193238A1 US 20180193238 A1 US20180193238 A1 US 20180193238A1 US 201415106933 A US201415106933 A US 201415106933A US 2018193238 A1 US2018193238 A1 US 2018193238A1
- Authority
- US
- United States
- Prior art keywords
- skin
- magnetic powder
- pack agent
- aqueous
- beauty care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003796 beauty Effects 0.000 title claims abstract description 122
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 181
- 239000006247 magnetic powder Substances 0.000 claims abstract description 139
- 230000005291 magnetic effect Effects 0.000 claims abstract description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000007864 aqueous solution Substances 0.000 claims abstract description 20
- 239000002562 thickening agent Substances 0.000 claims abstract description 20
- 239000002245 particle Substances 0.000 claims description 91
- 229910000859 α-Fe Inorganic materials 0.000 claims description 19
- 238000009826 distribution Methods 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 230000005415 magnetization Effects 0.000 claims description 14
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 13
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000003647 oxidation Effects 0.000 claims description 12
- 230000005294 ferromagnetic effect Effects 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 229910052595 hematite Inorganic materials 0.000 claims description 6
- 239000011019 hematite Substances 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 4
- 238000000790 scattering method Methods 0.000 claims description 4
- 239000003021 water soluble solvent Substances 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 232
- 230000000694 effects Effects 0.000 description 35
- 238000012360 testing method Methods 0.000 description 20
- 230000037394 skin elasticity Effects 0.000 description 19
- 238000010992 reflux Methods 0.000 description 18
- 238000004364 calculation method Methods 0.000 description 16
- 230000008595 infiltration Effects 0.000 description 15
- 238000001764 infiltration Methods 0.000 description 15
- 238000005259 measurement Methods 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 238000013459 approach Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- HYHGLHONPBPZGJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] phosphate Chemical group [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP(O)([O-])=O)=C1[O-] HYHGLHONPBPZGJ-YCWPWOODSA-L 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229940085991 phosphate ion Drugs 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000013008 thixotropic agent Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229910001172 neodymium magnet Inorganic materials 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- -1 polyoxyethylene Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229910052596 spinel Inorganic materials 0.000 description 3
- 239000011029 spinel Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229910001035 Soft ferrite Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000002889 diamagnetic material Substances 0.000 description 1
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 description 1
- VHPUZTHRFWIGAW-UHFFFAOYSA-N dimethoxy-di(propan-2-yl)silane Chemical compound CO[Si](OC)(C(C)C)C(C)C VHPUZTHRFWIGAW-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000398 iron phosphate Inorganic materials 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- POPACFLNWGUDSR-UHFFFAOYSA-N methoxy(trimethyl)silane Chemical compound CO[Si](C)(C)C POPACFLNWGUDSR-UHFFFAOYSA-N 0.000 description 1
- DRXHEPWCWBIQFJ-UHFFFAOYSA-N methyl(triphenoxy)silane Chemical compound C=1C=CC=CC=1O[Si](OC=1C=CC=CC=1)(C)OC1=CC=CC=C1 DRXHEPWCWBIQFJ-UHFFFAOYSA-N 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 1
- XYJRNCYWTVGEEG-UHFFFAOYSA-N trimethoxy(2-methylpropyl)silane Chemical compound CO[Si](OC)(OC)CC(C)C XYJRNCYWTVGEEG-UHFFFAOYSA-N 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- 230000036448 vitalisation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/47—Magnetic materials; Paramagnetic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/624—Coated by macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
Definitions
- aqueous pack agent containing a water, a magnetic powder, a thickener and a charged iontophoretic component
- the aqueous pack agent is lack of moisture and may be formed into a sticky mass. In this case, the user may feel un-comfortability such as roughness when the aqueous pack agent is brought into contact to the skin. In some cases, the aqueous pack agent brought into contact to the skin may cause an extremely strong stimulus to the skin.
- the aqueous pack agent may contain a surfactant.
- the surfactant has an action of dispersing a magnetic powder in the aqueous pack agent. Accordingly, in the aqueous pack agent containing a surfactant, the state where the magnetic powder is dispersed can be more reliably realized. As a result, the aqueous pack agent provides a smooth paste-like appearance and the user feels smoother spreading over the skin.
- ferromagnetic metal for example, a single metal such as iron, nickel and cobalt, and an alloy containing at least one of these metal elements are mentioned. Note that these single metals and alloys may usually contain other chemical components such as inevitable impurities.
- the fatty acid coating film may contain a structure derived from a fatty acid such as lauric acid, myristic acid, stearic acid, palmitic acid, oleic acid and linoleic acid.
- the fatty acid coating film can be formed by subjecting the magnetic powder to a surface treatment with a solution containing a fatty acid.
- the particle size distribution of the magnetic powder has a distribution pattern in which the content of particles having an excessively small particle diameter and the content of particles having excessively large particle diameter are both small.
- the mean volume particle diameter of the magnetic powder is more preferably 50 to 75 ⁇ m.
- a magnet 3 is allowed to approach the aqueous pack agent 1 applied to the skin 2 , as shown in FIG. 1 ( b ). In this manner, the magnetic powder 11 is attracted by the magnet 3 and removed from the skin surface 21 by the magnetic force. Simultaneously with the magnetic powder 11 , a used aqueous pack agent 100 and dirt 200 of the skin 2 and others attached to the magnetic powder 11 are attracted and removed from the skin surface 21 by the magnetic force.
- the magnet 3 used in this step may be a permanent magnet such as a ferrite magnet and a neodymium magnet or an electromagnet.
- a pulse voltage is applied between the working electrode 41 and the counter electrode 42 in a plurality of times while controlling the potential difference between the electrodes such that the electrical potential of the working electrode 41 is lower than that of the counter electrode 42 .
- the iontophoretic current becomes a negative pulse current as shown in basic waveform F 1 of FIG. 2 .
- the iontophoretic current flows through the skin 2 and infiltration of L-ascorbic acid 2-phosphate ion 131 into the skin is facilitated.
- a method for manufacturing the magnetic powder 11 used in the aqueous pack agent 1 and properties of the magnetic powder 11 are as follows:
- a slurry was prepared by adding a water to a hematite (Fe 2 O 3 ) powder so as to have a solid content of 55 mass %. Subsequently, 1 mass % of a polyvinyl alcohol relative to the solid content of the slurry, 0.9 mass % of a carbon black and 0.5 mass % of a polycarboxylate salt were added to the resultant slurry. Thereafter, a water was added to the mixture to prepare a slurry having 55 mass % of a solid content. Then, the resultant slurry was stirred by use of an attritor for one hour, and then, spherically granulated by use of a spray dryer. The grain sizes of the granules obtained were controlled by a gyro shifter.
- the resultant calcined product was pulverized and classified by use of a gyro shifter in combination with an air classifier. In this manner, a particle size distribution was controlled. Thereafter, particles having a large magnetic susceptibility were selected by electromagnetic separation to obtain the magnetic powder 11 .
- the magnetic powder 11 contained a chemical component having 89.7 mass % of magnetite, 4.1 mass % of hematite and 6.2 mass % of wustite.
- the beauty care instrument 7 has a virtually rod-like body portion 71 , an attraction head 72 provided at one of the ends of the body portion 71 and a working electrode 41 provided at the other end of the body portion 71 .
- the attraction head 72 has a magnetic force generation surface 720 for attracting and removing the aqueous pack agent 1 applied to the skin 2 by the magnetic force, as shown in FIG. 6 and FIG. 7 .
- FIG. 4 shows that the beauty care instrument 7 has a virtually rod-like body portion 71 , an attraction head 72 provided at one of the ends of the body portion 71 and a working electrode 41 provided at the other end of the body portion 71 .
- the attraction head 72 has a magnetic force generation surface 720 for attracting and removing the aqueous pack agent 1 applied to the skin 2 by the magnetic force, as shown in FIG. 6 and FIG. 7 .
- the beauty care instrument 7 is constituted in such a design that an iontophoretic current can be supplied to the contact portion at which the working electrode 41 remains in contact with the skin 2 .
- the body portion 71 houses a power supply section 733 for supplying a power to the working electrode 41 and a control section 73 for controlling the current to be supplied to the contact portion.
- control microcomputer 730 turns on the delay timer 730 d and executes step S 2 of waiting the elapse of the predetermined time.
- the predetermined time can be appropriately set within the range of 50 to 1000 milliseconds by the delay timer 730 d of this example.
- control microcomputer 730 executes step S 6 of determining whether the working electrode 41 and the counter electrode 42 are in contact with a human body based on the results of comparison between the potential difference and a predetermined threshold L (see, FIG. 11 ) in the calculation section 730 b . If the potential difference obtained in step S 5 is less than threshold L, the control microcomputer 730 determines that at least one of the working electrode 41 and the counter electrode 42 is not in contact with a human body (“No” in Step S 6 ). In this case, the control microcomputer 730 instructs to go back to step S 2 of driving the delay timer 730 d .
- the determination of the contact state in step T 3 is made based on the determination whether or not the potential difference values between both ends of the resistor 732 a due to a pulse current (F 2 , FIG. 2 ) in reset pulse step S 9 are continuously lower than threshold L, at predetermined number of times.
- the control microcomputer 730 of this example determines that at least one of the working electrode 41 and the counter electrode 42 is not in contact with a human body.
- the control section 73 has, the reflux section 732 , which takes in the current flowing through a human body and sends the current to the power supply section 733 ; and is constituted such that the potential difference of the reflux section 732 from the ground potential is measured as an electrical characteristic value and if the potential difference is a predetermined threshold or more, it is determined that the working electrode 41 and the counter electrode 42 are both in contact with a human body. Accordingly, the circuit design of the control section 73 can be easily simplified, as mentioned above; at the same time, the accuracy in determining that the working electrode 41 and the counter electrode 42 are in contact with a human body can be improved.
- the beauty care instrument 7 successfully improves convenience in continuously carrying out a work step of removing dirt of skin and waste and a work step of allowing a beauty component to infiltrate into the skin.
- iontophoresis can be carried out by the beauty care instrument 7 having e.g., the working electrode 41 and the control section 73 without providing the attraction head 72 .
- the shape of the beauty care instrument 7 is not limited to that shown in Example 2 and can be variously modified.
- the body portion 71 may have a spherical or cylindrical shape.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- The present invention relates to a beauty care method for skin beauty.
- As a beauty care method for skin beauty, a method in which a pack agent is used is known. The pack agent is constituted to remove e.g., dirt and waste of the skin together with a used pack agent. Methods for removing such a used pack agent from the skin conventionally range from wiping with e.g., cotton to washing away with e.g., warm water. Recently, easier methods than these conventional ones have been desired for removing a used pack agent.
- For example,
Patent Document 1 proposes a skin cleaning cream, which is prepared by adding a powder constituted of magnetized particles or particles that can be magnetized to an excipient serving as an application base. The skin cleaning cream is, for example, used as follows: after the skin cleaning cream is applied to the skin, a magnet or the like is allowed to approach the skin cleaning cream on the skin surface. Therefore, a magnetic force acts on the powder contained in the skin cleaning cream, and attracts the powder. Subsequently, the used skin cleaning cream attached to the powder and dirt of the skin and others are attracted and removed by the magnetic force from the skin surface together with the powder. In this manner, the skin cleaning cream is easily removed from the skin surface. - In the meantime, after removing dirt of the skin and others by use of the pack agent, it is also effective for skin beauty to allow beauty components such as nutritional components that supply nutritive substance to the skin and a whitening ingredient for producing a whitening effect to infiltrate into the skin to obtain beauty effects of these beauty components. For example,
Patent Document 2 discloses a method for promoting infiltration of a beauty component by iontophoresis. The iontophoresis is a method of promoting infiltration of a beauty component to the skin by applying a weak current to a desired part into which the beauty component is to be supplied to allow a charged beauty component to migrate into the skin. - Patent Document 1: JP-B-61-3765
- Patent Document 2: JP-B-4768404
- A higher beauty effect can be obtained by carrying out removal of dirt of the skin and others by the pack agent and iontophoresis in succession. However, for carrying out these in succession, there are the following problems.
- More specifically, a conventional pack agent containing a magnetic powder uses an excipient containing an oily ingredient such as Vaseline as a main component. Because of this, the oily ingredient at least partly remains on the skin surface and forms an oil film after the pack agent is attracted and removed from the skin by the magnetic force. In addition, since the oil film is insulative, it is difficult to apply a weak current to the skin for iontophoresis.
- As mentioned above, it is difficult for a conventional pack agent containing a magnetic powder to carry out attraction and removal of dirt of the skin and others and iontophoresis in succession, and the oil film must be removed from the skin surface before iontophoresis. For the reason, an excellent beauty effect produced by carrying out removal of dirt of the skin and others and iontophoresis in succession is rarely obtained. Since a step of removing the oil film from the skin surface must be performed in addition to removal of a used pack agent and iontophoresis, the working process becomes complicated.
- To avoid the aforementioned problem, a method in which an aqueous pack agent that rarely forms the oil film on the skin surface is used is conceivable. However, in the case, it is difficult to obtain a pack agent in a paste-like appearance suitable for application to the skin by adding a magnetic powder to an aqueous pack agent.
- The present invention has been made in view of the aforementioned background and is directed to providing a beauty care method that can provide a more excellent beauty effect by a simple procedure.
- According to an aspect of the present invention, there is provided a beauty care method having
- a step of applying an aqueous pack agent containing a water, a magnetic powder, a thickener and a charged iontophoretic component to the skin,
- a step of applying magnetic force to the magnetic powder in the aqueous pack agent applied to the skin to attract and remove the magnetic powder from the skin surface while leaving an aqueous solution of the iontophoretic component on the skin surface, and
- a step of applying an iontophoretic current to the skin with the aqueous solution left to allow the iontophoretic component to infiltrate into the skin.
- In the beauty care method, first, the step of applying an aqueous pack agent to the skin is carried out. Since the aqueous pack agent contains a water, a magnetic powder and a thickener, the magnetic powder is dispersed in the aqueous pack agent and the aqueous pack agent is obtained in a paste-like appearance suitable for application to the skin, with the result that the user feels smooth application to the skin.
- Then, the step of applying a magnetic force to the magnetic powder in the aqueous pack agent applied to the skin to attract and remove the magnetic powder from the skin surface is carried out. In this step, the magnetic powder is attracted and removed from the skin surface by the magnetic force; at the same time, the used aqueous pack agent attached to the magnetic powder and dirt of the skin and others are attracted and removed from the skin surface by the magnetic force.
- Since the aqueous pack agent is aqueous, an oil film is rarely formed on the skin surface after the used aqueous pack agent is attracted and removed. Thus, the amount of a substance which inhibits the infiltration of a beauty component, such as dirt of a skin, waste or an oil film, is low on the skin surface after the aqueous pack agent is attracted and removed. The resultant skin surface is in the state where a beauty component easily infiltrates. Since an iontophoretic component is blended in advance in the aqueous pack agent, the aqueous solution containing the ionized iontophoretic component can remain applied onto the skin surface even though the aqueous pack agent is attracted and removed from the skin surface.
- Thereafter, a step of applying an iontophoretic current to the skin on which the aqueous solution is applied, to allow the iontophoretic component to infiltrate into the skin, is carried out. As described above, the aqueous pack agent rarely forms an oil film on the skin surface after the attraction and removal. Accordingly, after the aqueous pack agent is attracted and removed from the skin surface, an iontophoretic current can be applied to the skin without removing the oil film. Owing to this, the charged iontophoretic component can be allowed to migrate into the skin, and infiltration of the iontophoretic component into the skin can be facilitated. As mentioned above, iontophoresis cannot be carried out immediately after a pack agent is attracted and removed by in conventional pack agents containing an oily ingredient as a main component.
- As mentioned above, in the beauty care method, an aqueous pack agent is applied to the skin and then the aqueous pack agent is attracted and removed by the magnetic force. Owing to the sequential operations, a working step of attracting and removing dirt of the skin and others and a working step of applying an aqueous solution containing an iontophoretic component to the skin can be continuously carried out, and further iontophoresis can be continuously carried out. Accordingly, an excellent beauty effect can be easily obtained by carrying out removal of dirt of the skin and others and iontophoresis in succession. Since a working step of removing an oil film from the skin surface is not required between the removal of skin dirt and the iontophoresis, the working process can be further simplified.
- As described in the foregoing, according to the beauty care method, a beauty effect can be more excellently obtained by simple steps.
-
FIG. 1(a) is an illustration of a state in which an aqueous pack agent is applied in Example 1, (b) is an illustration of a state in which the aqueous pack agent is attracted and removed by the magnetic force, and (c) is an illustration of a state in which iontophoresis is carried out. -
FIG. 2 shows a waveform chart of an iontophoretic current in Example 1. -
FIG. 3 is a graph showing a change in skin elasticity before and after the test in Example 1. -
FIG. 4 is a perspective view of the beauty care instrument described in Example 2. -
FIG. 5 is a plan view of the beauty care instrument described in Example 2, as viewed from the top, i.e., an opposite side to the magnetic force generation surface. -
FIG. 6 is a plan view of the beauty care instrument described in Example 2, as viewed from the bottom, i.e., the magnetic force generation surface. -
FIG. 7 is a sectional view along the line defined by A-A ofFIG. 5 . -
FIG. 8 is a block diagram describing the constitution of the control section of the beauty care instrument described in Example 2. -
FIG. 9 is a flowchart showing the operation of the beauty care instrument described in Example 2. -
FIG. 10 is a flowchart showing the operation of a skin detecting function while iontophoretic current flows, described in Example 2. -
FIG. 11 is a waveform chart showing potential difference produced between both ends of the resistor section in step S5, when the working electrode and the counter electrode of the beauty care instrument described in Example 2 are in contact with a human body. -
FIG. 12 is a view showing how to remove an aqueous pack agent by use of the beauty care instrument described in Example 2. -
FIG. 13 is a view showing how to apply an iontophoretic current to the skin by use of the beauty care instrument described in Example 2. -
FIG. 14 is a perspective view of the beauty care instrument in attracting and removing a magnetic powder, as viewed obliquely from upward. -
FIG. 15 is a perspective view of the beauty care instrument in attracting and removing a magnetic powder, as viewed obliquely from downward. - In the beauty care method, the iontophoresis is carried out by bringing two electrodes into contact with the skin and applying an iontophoretic current between the two electrodes. In the following description, one of the two electrodes is called as a working electrode and the other electrode is called as a counter electrode, for convenience sake. The working electrode is defined as the electrode to be brought into contact with a desired part in which an iontophoretic component is allowed to infiltrate.
- The iontophoretic current is a current having a single-polarity and exhibiting various waveforms, such as DC current, pulse current and so on. The polarity of the iontophoretic current is defined in conformity to the polarity of the charge of the iontophoretic component. For example, if the iontophoretic component is present in the state of a negative ion in the aqueous solution, a voltage is applied between the two electrodes such that the electrical potential of the working electrode is lower than that of the counter electrode. In this manner, an iontophoretic current flows between the working electrode serving as a cathode and the counter electrode serving as an anode. the iontophoretic component is repelled from the working electrode and migrates to the counter electrode sides, i.e., into the skin. As a result, infiltration of the iontophoretic component into the skin is facilitated.
- The current value of the iontophoretic current can be specified to fall within the range of, for example, 100 to 1000 μA. If the current value of the iontophoretic current is less than 100 μA, the effect of facilitating infiltration of a beauty component into the skin may be insufficient and the beauty effect that the user can feel may decrease. If the current value of the iontophoretic current exceeds 1000 μA, the effect of facilitating infiltration of a beauty component almost reaches a plateau.
- As the current value of the iontophoretic current increases, infiltration of a beauty component into the skin is facilitated; whereas, in some cases, the user may feel a sense of discomfort at a contact part of the skin with the working electrode. To sufficiently obtain the effect of facilitating infiltration of the beauty component while avoiding such a problem, the current value of the iontophoretic current is preferably set to be 100 to 240 μA.
- For the aqueous pack agent, the solvent can be appropriately selected to obtain desired properties such as texture and spreadability when applied to the skin and to obtain a paste-like appearance sufficient to be applied to the skin. For example, the aqueous pack agent may contain a water as a solvent. In this case, since the aqueous pack agent contains the charged iontophoretic component, an aqueous solution containing the iontophoretic component remains on the skin surface after the magnetic powder is removed from the skin, as described above.
- The solvent of the aqueous pack agent may be constituted of a water-soluble solvent alone without water. As the water-soluble solvent, for example, a water soluble alcohol such as ethanol and isopropyl alcohol, and glycerin can be used. In this case, the aqueous pack agent must contain a component, such as ascorbate, which is constituted to produce an iontophoretic component when dissolved in water. In the case of the aqueous pack agent designed in this way, when a magnetic powder is removed from the skin, the aforementioned component remains on the skin surface. The component remaining on the skin surface is ionized with moisture that the skin itself has or moisture in the air and produces an iontophoretic component. Because of this, even if the aqueous pack agent does not contain water, iontophoresis can be performed.
- In the aqueous pack agent to be used in the beauty care method, the more the content of a component insoluble in water decreases, the more rarely the aqueous pack agent forms an oil film on the skin surface and the easier the aqueous pack agent has excellent performance. Accordingly, in the aqueous pack agent, if the total of components excluding a magnetic powder is specified as 100 mass %, the content of a component insoluble in water is limited to be 50 mass % or less. In order to suppress formation of an oil film on the skin surface, the content of the component insoluble in water is preferably 40 mass % or less and more preferably 30 mass % or less.
- If a water is contained in the aqueous pack agent as a solvent, a thickener must be contained together with water. The thickener has an action of increasing the viscosity of the aqueous pack agent such that the aqueous pack agent has an appropriate viscosity. Accordingly, the magnetic powder is easily dispersed in the aqueous pack agent, and a paste-like aqueous pack agent suitable for application to the skin is easily obtained. The thickener also has an action of adhering particles constituting the magnetic powder when applied to the skin. Thus, in the aqueous pack agent, particles of the magnetic powder easily adhere to each other, with the result that the used aqueous pack agent is easily removed from the skin surface in the form of a continuous film. Consequently, the aqueous pack agent can be easily attracted and removed from the skin surface, and the used aqueous pack agent and fine particles in the magnetic powder are suppressed from remaining on the skin surface.
- In the case where an aqueous pack agent does not contain a thickener, since the viscosity of the aqueous pack agent does not increase, some problems occur such as precipitation of the magnetic powder by gravity, dripping of the aqueous pack agent from the skin surface due to low viscosity and so on. Because of these problems, it is difficult to apply such an aqueous pack agent to the skin.
- As the thickener, a conventional thickener for use in cosmetics can be used. Examples of the thickener include a glycerin, (acrylates/alkyl acrylate (C10-30)) cross polymer, a cellulose derivative, xanthan gum, guar gum, starch and a derivative thereof, alginate and a derivative thereof, agar, sodium polyacrylate, a carboxyvinyl polymer and bentonite. These thickeners may be used alone or in combination.
- The aqueous pack agent preferably contains 10 to 45 mass % of glycerin relative to the total aqueous pack agent, as a thickener. In this case, the adhesive force acting between particles of the magnetic powder increases, a continuous film-like structure of the aqueous pack agent tends not to easily tear when the used aqueous pack agent is attracted and removed from the skin. As a result, the aqueous pack agent is more easily attracted and removed from the skin surface and the used aqueous pack agent and others can be prevented from remaining on the skin surface.
- The content of water serving as a solvent is preferably 5 to 73 mass % relative to the total aqueous pack agent. If the content of water falls within a specific range as mentioned above, the aqueous pack agent tends to be obtained in a smooth paste-like appearance, in which the magnetic powder is dispersed. As a result, the aqueous pack agent is easily spread over when applied to the skin and the user feels smooth spreading over the skin.
- If the content of water is less than 5 mass %, the aqueous pack agent is lack of moisture and may be formed into a sticky mass. In this case, the user may feel un-comfortability such as roughness when the aqueous pack agent is brought into contact to the skin. In some cases, the aqueous pack agent brought into contact to the skin may cause an extremely strong stimulus to the skin.
- Consequently, it becomes difficult to spread the aqueous pack agent over the skin. To obtain an aqueous pack agent having a paste-like appearance suitable for application to the skin, the content of water is preferably 5 mass % or more and more preferably 6 mass % or more.
- In contrast, if the content of water exceeds 73 mass %, it is difficult to obtain an effect of increasing viscosity due to a thickener, with the result that the viscosity of the aqueous pack agent may be extremely reduced. In this case, the amount of magnetic powder contained in the aqueous pack agent applied to the skin surface becomes insufficient due to precipitation of the magnetic powder by gravity. If the amount of magnetic powder is insufficient, the magnetic force acting on the whole magnetic powder becomes insufficient when a magnet or the like is allowed to approach. In some cases, the used aqueous pack agent and others conceivably remain on the skin surface. Also in this case, due to low viscosity, the aqueous pack agent may drip from the skin surface. Thus, in order to obtain an aqueous pack agent having an appropriately large viscosity, the content of water is preferably 73 mass % or less, more preferably 30 mass % or less and further preferably 15 mass % or less.
- It is preferable that the content of the magnetic powder relative to the whole aqueous pack agent is 15 to 80 mass %. In this case, since the amount of magnetic powder contained in the aqueous pack agent applied to the skin is relatively large, the magnetic force acting on the whole magnetic powder increases when a magnet or the like is allowed to approach the aqueous pack agent. As a result, the used aqueous pack agent can be easily attracted and removed from the skin surface together with dirt of the skin and others, and the aqueous pack agent and others can be prevented from remaining on the skin surface.
- If the content of the magnetic powder is less than 15 mass %, since the content of the magnetic powder is low, when a magnet or the like is allowed to approach, the magnetic force acting on the whole magnetic powder may become insufficient. As a result, it becomes difficult to attract and remove the used aqueous pack agent from the skin surface. In order to easily attract and remove the aqueous pack agent from the skin surface, the content of the magnetic powder is preferably 15 mass % or more, more preferably 30 mass % or more and further preferably 50 mass % or more.
- In contrast, if the content of the magnetic powder exceeds 80 mass %, since the contents of water and a thickener become insufficient, the aqueous pack agent may be formed into a sticky mass. Because of this, it is difficult to spread the aqueous pack agent over the skin. Thus, in order to obtain the aqueous pack agent in a paste-like appearance suitable for application to the skin, the content of the magnetic powder is preferably 80 mass % or less, more preferably 75 mass % or less and further preferably 70 mass % or less.
- The viscosity of the aqueous pack agent is preferably 9000 mPa·s or more. In this case, the dispersed state of the magnetic powder in the aqueous pack agent can be maintained for a longer time. Accordingly, the state where a sufficient amount of magnetic powder for attraction and removal is contained in the aqueous pack agent applied to the skin surface can be more easily realized. As a result, the magnetic powder and the used aqueous pack agent can be easily attracted and removed from the skin surface, and the used aqueous pack agent and fine particles in the magnetic powder are more suppressed from remaining on the skin surface.
- The aqueous pack agent may contain a thixotropic agent for imparting thixotropy. The aqueous pack agent having thixotropy has a high viscosity in the state where the aqueous pack agent does not flow during e.g., storage. Whereas, in the state where the pack agent flows during e.g., application of the agent to the skin, the viscosity of the aqueous pack agent decreases. Accordingly, in the aqueous pack agent containing a thixotropic agent, precipitation of the magnetic powder can be prevented when the aqueous pack agent is in storage. In contrast, when applied to the skin, the aqueous pack agent is likely to have a suitable viscosity for application. As a result, the aqueous pack agent is suitably applied to the skin while preventing precipitation of a magnetic powder.
- As the thixotropic agent, a conventional thixotropic agent for use in cosmetics, such as bentonite, 12-hydroxystearic acid and crystalline cellulose, is used.
- The aqueous pack agent may contain a surfactant. The surfactant has an action of dispersing a magnetic powder in the aqueous pack agent. Accordingly, in the aqueous pack agent containing a surfactant, the state where the magnetic powder is dispersed can be more reliably realized. As a result, the aqueous pack agent provides a smooth paste-like appearance and the user feels smoother spreading over the skin.
- As the surfactant, a conventional surfactant for use in cosmetics can be used. Examples of the surfactant include PEG-7 glyceryl cocoate, polyglyceryl-10 laurate, an alkyl sulfate, an acylamino acid salt, a polyoxyethylene alkyl ether sulfate, an alkyl ether phosphate, an alkyl polyethylene glycol ether, a glycerol polypropylene glycol ether, an alkyl polyglycerol ether and an ethylene oxide-propylene oxide block copolymer. These surfactants may be used alone or in combination.
- The aqueous pack agent may further contain a beauty component providing a beauty effect on the skin, other than the aforementioned components. As described above, the aqueous pack agent rarely forms an oil film on the skin surface after the used aqueous pack agent is attracted and removed. Thus, the amount of a substance which inhibits the infiltration of a beauty component, such as dirt of the skin, waste or an oil film is low on the skin surface after the aqueous pack agent is attracted and removed. In this state, a beauty component easily infiltrates. The beauty component, which is blended in advance in the aqueous pack agent, can remain applied onto the skin surface even though the aqueous pack agent is attracted and removed from the skin surface. Accordingly, the beauty component more easily infiltrates into the skin surface and a more excellent beauty effect is easily obtained.
- Examples of the beauty component to be used herein include a whitening component such as an ascorbic acid derivative, kojic acid, arbutin and tranexamic acid; a nutritional component such as an amino acid, a vitamin, a plant extract and a microbially fermented product; and a moisturizing component.
- The aqueous pack agent may contain additives usually used in cosmetics other than the aforementioned components. Examples of the additives include a lubricant, an anti-microbial agent, a fragrance and a pH adjusting agent. These additives can be appropriately added as long as the effects of the present invention are not undermined.
- It is preferable that the aqueous pack agent has an electrical conductivity of 20 μS/cm or more at 25° C. In this case, since a weak current for facilitating infiltration of an iontophoresis component into the skin easily flows, iontophoresis can be easily performed.
- As the magnetic powder to be contained in the aqueous pack agent, a magnetic powder constituted of a ferromagnetic material is used. When the magnetic powder comes into direct contact with e.g., water contained in the aqueous pack agent, the magnetic powder is oxidized and rust may be formed. The magnetic powder oxidized to the extent that rust is produced, is hardly attracted and removed from the skin since the magnetic property of the powder deteriorates. Also, rust of the magnetic powder is not preferable in blending with an aqueous pack agent in view of appearance. Accordingly, it is preferable to use a magnetic power capable of suppressing formation of rust for a long period of time.
- For example, the magnetic powder is constituted of a ferromagnetic metal and an oxidation resistant film may be formed on the surface of each particles constituting the magnetic powder. In this case, sufficiently large magnetic force can be applied to the whole magnetic powder by a ferromagnetic metal when a magnet or the like is allowed to approach. Accordingly, the magnetic powder can be easily attracted and removed from the skin surface together with the used aqueous pack agent.
- Owing to the presence of the oxidation resistant film, it is possible to suppress direct contact of the particles with a material that may serve as an oxidation agent, such as water, contained in the aqueous pack agent. Consequently, rust formation of the magnetic powder can be suppressed for a long period of time. As the result of suppressing the contact between the particles and e.g., water, the magnetic powder is rarely oxidized and the magnetic property can be maintained for a long period of time.
- As mentioned above, the magnetic powder constituted of a ferromagnetic metal and having an oxidation resistant film can maintain excellent magnetic property for a long period of time. Accordingly, an aqueous pack agent containing the magnetic powder can maintain its performance for a long period of time.
- As the aforementioned ferromagnetic metal, for example, a single metal such as iron, nickel and cobalt, and an alloy containing at least one of these metal elements are mentioned. Note that these single metals and alloys may usually contain other chemical components such as inevitable impurities.
- As the oxidation resistant film, a wide variety of materials can be employed as long as they suppress direct contact between the particles and e.g., water. Examples of the oxidation resistant film that can be used include an inorganic coating film, a fatty acid coating film, a silane coating film and a resin coating film. The inorganic coating film can be formed by subjecting the magnetic particle to a treatment with a phosphate salt such as iron phosphate, zinc phosphate, calcium phosphate and manganese phosphate.
- The fatty acid coating film may contain a structure derived from a fatty acid such as lauric acid, myristic acid, stearic acid, palmitic acid, oleic acid and linoleic acid. The fatty acid coating film can be formed by subjecting the magnetic powder to a surface treatment with a solution containing a fatty acid.
- The silane coating film may contain a structure derived from an alkylalkoxysilane such as methyltrimethoxysilane, dimethyldimethoxysilane, trimethylmethoxysilane, methyltriethoxysilane, methyltriphenoxysilane, ethyltrimethoxysilane, n-propyltrimethoxysilane, diisopropyldimethoxysilane and isobutyltrimethoxysilane. The silane coating film can be formed by treating the surface of the magnetic powder with an alkoxysilane.
- Examples of the resin constituting a resin coating film that can be used include a resin such as an acrylates copolymer, a polyvinyl alcohol, a polyvinyl pyrrolidone, a methoxy ethylene-maleic anhydride copolymer, a cationic cellulose, a polyacrylic acid ester copolymer, a methacrylic acid ester copolymer, an epoxy resin and a silicone resin. The resin coating film can be formed by applying a resin as mentioned above to the surface of the magnetic powder.
- The magnetic powder may contain a ferromagnetic ferrite as a main component. The “main component” herein refers to a chemical component contained in the largest amount. The magnetic powder usually contains, other than a ferromagnetic ferrite serving as a main component, e.g., an iron-based oxide such as wustite and hematite each having a different degree of oxidation, and inevitable impurities.
- A ferrite is low in variation of magnetic property and color tone. Accordingly, an aqueous pack agent containing the magnetic powder having a ferrite as a main component can be reduced in variation in ease of attraction and removal and color tone. In addition, since a ferrite is an iron oxide, further oxidization of the magnetic powder rarely takes place in an aqueous pack agent. For the reason, even if the aqueous pack agent is stored for a long term, e.g., magnetic property of the magnetic powder rarely changes and performance can be maintained for a long term.
- A magnetic powder having a ferrite as a main component may have an oxidation resistant film on the surface. In this case, owing to the presence of the oxidation resistant film, the magnetic powder is more rarely oxidized. Thus, the aqueous pack agent can maintain performance for a long period of time.
- Examples of the ferromagnetic ferrite include a spinel ferrite, a magneto-plumbite ferrite, a garnet ferrite, a perovskite ferrite and so on. Of these ferrites, a soft ferrite high in saturation magnetization and low in both residual magnetization and magnetic coercive force is preferably contained as a main component of the magnetic powder. Examples of the soft ferrite include a spinel ferrite having a formula represented by (MO)x(Fe2O3)y (where x+y=100 mol %, M is one or two or more metal elements selected from metallic elements e.g., Fe, Mn, Mg, Sr, Ca, Ba, Cu, Zn, Ni, Li and Co). Of the spinel ferrites, a ferrite having high saturation magnetization is preferably used.
- In the magnetic powder to be used in the aqueous pack agent, the number of the elements constituting a ferrite serving as a main component is preferably small. Thus, magnetite (Fe3O4) having high saturation magnetization and constituted of two elements, Fe and O, is further preferably contained as a main component of the magnetic powder.
- It is preferable that the magnetic powder has a chemical component consisting of 80 mass % or more of magnetite and the balance being wustite, hematite and inevitable impurities. In this case, the ratio of a diamagnetic material in the magnetic powder decreases, and thus the magnetic force acting on the whole magnetic powder increases. As a result, the aqueous pack agent can be more efficiently attracted and removed. Since the degree of oxidation of wustite is low compared to e.g., magnetite, if the content of wustite is reduced, it is likely to avoid further oxidation of the magnetic powder. Consequently, the performance of the aqueous pack agent can be stabilized for a long term.
- The mean volume particle diameter of a magnetic powder is preferably 20 to 150 μm and more preferably 50 to 75 μm. In this case, it is possible to easily attract and remove the used aqueous pack agent from the skin surface. The mean volume particle diameter of the magnetic powder can be calculated in terms of 50% cumulative particle diameter (median diameter) obtained in the volume distribution mode in under-sieve representation of the particle size distribution obtained by the laser diffraction scattering method.
- If the mean volume particle diameter is less than 20 μm, the particle size distribution of the magnetic powder tends to have a distribution pattern in which the content of an excessively small particle size is large. The magnetic force acting on each of the particles decreases as the size of the particle reduces. Because of this, particles having an excessively small particle diameter are difficult to be attracted by a magnet or the like and tend to remain on the skin surface. Also in this case, the magnetic force acting on the whole magnetic powder becomes weak, with the result that the used aqueous pack agent is likely to remain on the skin surface.
- In contrast, if the mean volume particle diameter exceeds 150 μm, the particle size distribution has a distribution pattern in which the content of an excessively large particle diameter is large. In this case, the user feels rough when the aqueous pack agent containing the magnetic powder is used. Likewise, the sense of use may deteriorate.
- As mentioned above, the aqueous pack agent having a magnetic powder in which the mean volume particle diameter is controlled to fall within 20 to 150 μm provides an excellent sense of use because fine particles contained in the magnetic powder and the used aqueous pack agent are suppressed from remaining on the skin surface.
- The magnetic powder preferably has a mean volume particle diameter being 50 to 75 μm as determined from a particle size distribution obtained by a laser diffraction scattering method, a content of particles with a particle diameter being less than 37 μm of 15 mass % or less, and a content of particles with a particle diameter being 105 μm or more of 5 mass % or less.
- The content of particles having a particle diameter being less than 37 μm (hereinafter sometimes referred to as “small-diameter particles”) can be measured in terms of, for example, the amount of particles that can pass through a standard sieve having a nominal size of 37 μm (400 meshes).
- The content of particles having a particle diameter being 105 μm or more (hereinafter sometimes referred to as “large-diameter particles”) can be measured in terms of, for example, the amount of particles that cannot pass through a standard sieve having a nominal size of 105 μm (145 meshes).
- As described above, in order to obtain the aqueous pack agent rarely remaining on the skin surface and providing smooth application to the skin, it is preferable that the particle size distribution of the magnetic powder has a distribution pattern in which the content of particles having an excessively small particle diameter and the content of particles having excessively large particle diameter are both small. In other words, the mean volume particle diameter of the magnetic powder is more preferably 50 to 75 μm.
- However, it is difficult to reliably reduce the content of particles having an excessively small particle diameter only by controlling the mean volume particle diameter to fall within the range of 50 μm or more. Thus, it is important not only to control the mean volume particle diameter to fall within the range of 50 μm or more but also to regulate the content of small-diameter particles to be 15 mass % or less as mentioned above. The content of particles having an excessively small particle diameter can be certainly reduced by regulating the content of small-diameter particles to fall within the range of 15 mass % or less.
- Similarly, it is difficult to reliably reduce the content of particles having an excessively large particle diameter only by controlling the mean volume particle diameter to fall within the range of 75 μm or less. Thus, it is important not only to control the mean volume particle diameter to fall within the range of 75 μm or less but also to regulate the content of large-diameter particles to be 5 mass % or less as mentioned above. The content of particles having an excessively large particle diameter can be certainly reduced by regulating the content of large-diameter particles to fall within the range of 5 mass % or less.
- As mentioned above, the most suitable particle-size distribution in which the content of particles having an optimal diameter is large can be realized not only by controlling the mean volume particle diameter of the magnetic powder to fall within a specific range mentioned above but also by regulating both the content of small-diameter particles and the content of large-diameter particles. The magnetic powder, which is finely and carefully controlled so as to have a particle size distribution as mentioned above, exhibits the most suitable properties as the magnetic powder to be blended in an aqueous pack agent. Accordingly, the aqueous pack agent containing such the magnetic powder more rarely remains on the skin surface and provides a smoother application to the skin.
- The magnetic powder preferably has a saturation magnetization of 80 Am2/kg or more. In this case, the magnetization of the magnetic powder can be sufficiently increased and the magnetic force acting on the whole magnetic powder can be further increased. As a result, the used aqueous pack agent can be easily attracted and removed from the skin surface and can be prevented from remaining on the skin surface.
- Referring to
FIG. 1 toFIG. 3 , examples of the beauty care method will be explained. In the beauty care method of this example, first, a step of applying anaqueous pack agent 1, which comprises a water, a magnetic powder 11 containing a ferromagnetic ferrite as a main component, a thickener and a chargediontophoretic component 13, to the skin 2 (FIG. 1 (a) ) is carried out. Then, a step of applying magnetic force to the magnetic powder 11 contained in theaqueous pack agent 1 applied to theskin 2 and attracting and removing the magnetic powder 11 from theskin surface 21 by the magnetic force while leaving anaqueous solution 12 of theiontophoretic component 13 on the skin surface 21 (FIG. 1 (b) ) is carried out. Thereafter, a step of applying an iontophoretic current to theskin 2, on which theaqueous solution 12 is placed, to allow theiontophoretic component 13 to infiltrate into the skin 2 (FIG. 1 (c) ) is carried out. The beauty care method will be more specifically described below. - In the step of applying the
aqueous pack agent 1 to theskin 2, theaqueous pack agent 1 is applied to the entire surface of a desired part at which a beauty effect is to be provided. Theaqueous pack agent 1 is preferably applied with a thickness through which the color of theskin 2 cannot be seen. Note that, a detailed composition of theaqueous pack agent 1 will be described later. - In the step of attracting and removing the magnetic powder 11, a
magnet 3 is allowed to approach theaqueous pack agent 1 applied to theskin 2, as shown inFIG. 1 (b). In this manner, the magnetic powder 11 is attracted by themagnet 3 and removed from theskin surface 21 by the magnetic force. Simultaneously with the magnetic powder 11, a used aqueous pack agent 100 and dirt 200 of theskin 2 and others attached to the magnetic powder 11 are attracted and removed from theskin surface 21 by the magnetic force. Themagnet 3 used in this step may be a permanent magnet such as a ferrite magnet and a neodymium magnet or an electromagnet. - In contrast, an
aqueous solution 12 containing theiontophoretic component 13 is not attracted and removed together with the used aqueous pack agent 100 and others and remains on theskin surface 21. In this manner, theaqueous pack agent 1 is attracted and removed from theskin surface 21; at the same time, theaqueous solution 12 containing the ionizediontophoretic component 13 remains applied to theskin surface 21, as shown inFIG. 1 (b) . - In the step of introducing the
iontophoretic component 13 into theskin 2, as shown inFIG. 1 (c) , a workingelectrode 41 is allowed to be contact with theskin surface 21 on which theaqueous solution 12 containing theiontophoretic component 13 is applied; whereas, acounter electrode 42 is allowed to be in contact with theskin surface 211 where theaqueous solution 12 is not applied. In this state, a voltage is applied between the workingelectrode 41 and thecounter electrode 42 to supply an iontophoretic current to theskin 2. Note that, theiontophoretic component 13 used in this example is sodium L-ascorbic acid-2-phosphate. Sodium L-ascorbic acid-2-phosphate is ionized into an L-ascorbic acid 2-phosphate ion 131 and a sodium ion in theaqueous solution 12. Then, an anion, i.e., L-ascorbic acid 2-phosphate ion 131, is allowed to infiltrate into the skin by iontophoresis. Owing to this, beauty effects such as improvement of elasticity, wrinkles and age spots of skin and shrinkage of pores can be expected. - The iontophoretic current of this example is constituted of sequential repeats of an iontophoresis step of supplying an iontophoretic current (basic waveform F1) having a single-polarity to the contact portion between the working
electrode 41 and theskin 2; a reset pulse step of supplying a pulse current (basic waveform F2) having the other polarity to the contact portion; and a skin care step of supplying a current (basic waveform F3) in which polarity is alternately changed, to the contact portion, as shown inFIG. 2 . - In the iontophoresis step, a pulse voltage is applied between the working
electrode 41 and thecounter electrode 42 in a plurality of times while controlling the potential difference between the electrodes such that the electrical potential of the workingelectrode 41 is lower than that of thecounter electrode 42. Owing to this, the iontophoretic current becomes a negative pulse current as shown in basic waveform F1 ofFIG. 2 . The iontophoretic current flows through theskin 2 and infiltration of L-ascorbic acid 2-phosphate ion 131 into the skin is facilitated. - In the reset pulse step, a pulse voltage is applied once between the working
electrode 41 and thecounter electrode 42 while controlling the potential difference between the two electrodes such that the electrical potential of the workingelectrode 41 is higher than that of thecounter electrode 42. Owing to this, a positive pulse current flows through theskin 2, as shown in basic waveform F2 ofFIG. 2 . The reset pulse step is carried out in this manner to neutralize the bias in charge produced in theskin 2 in the iontophoresis step. - In the skin care step, a square wave, in which the high and low of the potential difference between the working
electrode 41 and thecounter electrode 42 alternately change, is applied to the both electrodes. Consequently, a square wave current, in which a positive polarity and negative polarity alternately change, as shown in basic waveform F3 ofFIG. 2 , flows through theskin 2. As mentioned above, if a weak current in which polarity alternately changes flows through theskin 2, effects such as vitalization of skin cells, improvement of lymph flow, improvement of blood circulation and improvement of metabolism, can be exerted. Accordingly, it is expected to obtain beauty effects such as improvement of elasticity of theskin 2 and beautifying theskin 2, by performing the skin care step. - In this example, the beauty effect of the
skin 2 obtained by the beauty care method was evaluated. The evaluation contents and evaluation results will be described below. - <Test Subject>
- Test subjects were eight Japanese women of 20 or more and less than 60 years old.
- <Test Conditions>
- [Aqueous Pack Agent 1]
- Specific composition of the
aqueous pack agent 1 to be applied to theskin 2 is as follows: -
Water 7.92 mass % Magnetic powder 11 65 mass % Thickener Glycerin 17.5 mass % Sodium polyacrylate 0.01 mass % Surfactant Polyglyceryl monolaurate 0.2 mass % Iontophoretic component 13 Sodium L-ascorbic acid-2-phosphate 0.1 mass % Lubricant, pH adjusting agent, balance preservative and etc. - [Magnetic Powder 11]
- A method for manufacturing the magnetic powder 11 used in the
aqueous pack agent 1 and properties of the magnetic powder 11 are as follows: - A slurry was prepared by adding a water to a hematite (Fe2O3) powder so as to have a solid content of 55 mass %. Subsequently, 1 mass % of a polyvinyl alcohol relative to the solid content of the slurry, 0.9 mass % of a carbon black and 0.5 mass % of a polycarboxylate salt were added to the resultant slurry. Thereafter, a water was added to the mixture to prepare a slurry having 55 mass % of a solid content. Then, the resultant slurry was stirred by use of an attritor for one hour, and then, spherically granulated by use of a spray dryer. The grain sizes of the granules obtained were controlled by a gyro shifter.
- The spherical granules controlled in grain size were heated at 1320° C. for 3 hours to reduce a raw-material hematite. In this manner, a calcined product containing magnetite as a main component was obtained. Note that, the granules was heated by use of a tunnel type electric furnace in a nitrogen atmosphere.
- The resultant calcined product was pulverized and classified by use of a gyro shifter in combination with an air classifier. In this manner, a particle size distribution was controlled. Thereafter, particles having a large magnetic susceptibility were selected by electromagnetic separation to obtain the magnetic powder 11.
- By performing surface treatment to the resultant magnetic powder 11 as mentioned above, a resin film consisting of an acrylates copolymer was formed on the surface of particles constituting the magnetic powder 11.
- Mean Volume Particle Diameter
- The mean volume particle diameter was calculated by the following method. First, a 0.2% aqueous solution of sodium hexametaphosphate was added to the magnetic powder 11. The resultant mixture was subjected to an ultrasonic treatment using an ultrasonic homogenizer (UH-3C, manufactured by Ultrasonic Engineering Co., Ltd.) for one minute to prepare a dispersion liquid of the magnetic powder 11. The dispersion liquid was introduced in a micro track particle-size analyzer (Model 9320-X100 manufactured by Nikkiso Co., Ltd.). Analysis was performed in the conditions: a refractive index of 1.81, a temperature of 25±5° C., and a humidity of 55±15%, to obtain a particle size distribution in accordance with the laser diffraction scattering method. From the resultant particle size distribution, a cumulative 50% particle diameter represented in terms of mesh size of sieves with a volume distribution mode, was calculated and employed as a mean volume particle diameter (median diameter).
- From the above results, the mean volume particle diameter of the magnetic powder 11 was about 70 μm.
- Contents of Small-Diameter Particles and Large-Diameter Particles
- The magnetic powder 11 was classified by a method according to JIS H 2601 using the standard sieves specified in JIS Z 8801. In this way, the content of small-diameter particles, namely, particles passed through the standard sieve having a nominal dimension of 37 μm (400 meshes) and the content of large-diameter particles, namely, particles not passed through a standard sieve having a nominal dimension of 105 μm (145 meshes) were measured.
- As a result, the content of the small-diameter particles in the magnetic powder 11 was 6.7 mass % and the content of the large-diameter particles was 0 mass %.
- Saturation Magnetization, Residual Magnetization and Magnetic Coercive Force
- Magnetic properties were measured by use of an integral type B-H tracer (Model: BHU-60, manufactured by Riken Denshi Co., Ltd.) in the following procedure. First, an H coil for measuring a magnetic field and a 4πI coil for measuring magnetization were placed between electromagnets and the magnetic powder 11 was put in the 4πI coil. Then, the current values of the electromagnets were changed to vary the magnetic field H. The outputs from the H coil and the 4πI coil were separately integrated. The output from H coil was plotted on the X-axis and the output from the 4πI coil was plotted on the Y-axis. In this manner, a hysteresis loop was drawn on a recording paper. From the hysteresis loop, saturation magnetization, residual magnetization and magnetic coercive force were calculated. Note that, the measurement condition for the hysteresis loop were as follows: sample amount of about 1 g, sample cell of 7 mmϕ±0.02 mm in inner diameter and 10 mm±0.1 mm in height, the number of turns of 4πI coil of 30; applied magnetic field of 3000 oersteds.
- As a result, the magnetic powder 11 had a saturation magnetization of 82 Am2/kg, a residual magnetization of 82 Am2/kg and a magnetic coercive force of 24 Oe.
- Chemical Components
- The composition ratio of magnetite (Fe3O4), hematite (Fe2O3) and wustite (FeO) was calculated in accordance with the following method using the X-ray diffraction method.
- As a measuring device, “X′PertPRO MPD” manufactured by PANalytical B.V. was used. Measurement was performed using a Co bulb (CoKα beam) as an X-ray source, a centralized optical system as an optical system and a fast detector, “X′Celarator”, by continuous scanning at a rate of 0.2°/sec. The measurement results were analyzed by analysis software, “X′PertHighScore” in the same manner as in ordinary crystal structure analysis of a powder to identify a crystal structure. Thereafter, an abundance ratio on a weight basis was calculated by refinement of the obtained crystal structure. Note that, when the abundance ratio of magnetite, hematite and wustite was calculated, Fe and O were regarded as essential elements.
- As the X-ray source to be used in the X-ray diffraction measurement, a Cu bulb may be used without a problem; however, in the case of a Fe-rich sample, the background noise becomes large compared to a peak of a measuring target. Thus, a Co bulb is preferably used. Even if collimating optics is used as the optical system, the same results can be obtained; however, X-ray intensity is low and a long time is required for measurement. For this reason, measurement in a centralized optical system is preferable. The speed of the continuous scanning is not particularly limited; however, the intensity of the main peak of magnetite, i.e., the peak in the (311) plane, became 50000 cps or more in order to obtain a sufficient S/N ratio for analyzing a crystal structure. A sample was set in a sample cell such that particles were not preferentially oriented in a specific direction. In this manner, measurement was performed.
- As a result, the magnetic powder 11 contained a chemical component having 89.7 mass % of magnetite, 4.1 mass % of hematite and 6.2 mass % of wustite.
- <Test Method>
- The right half of the face of a subject was used as a treatment portion and a treatment was applied to the treatment portion once every three days in accordance with the following method. First, cleansing and face-wash were performed. Thereafter, the
aqueous pack agent 1 was applied only to the treatment portion and the treatment portion was allowed to leave for three minutes. Three minutes later, themagnet 3 was allowed to approach theaqueous pack agent 1 applied to theskin 2, and the magnetic powder 11 and the usedaqueous pack agent 1 were attracted and removed from theskin 2. After the attraction and removal, the iontophoretic current shown inFIG. 2 was applied to the treatment portion for about 5 minutes. In this manner, the treatment was completed. - Note that, the left half of the face of each subject was used as a control portion and treated in accordance with the following procedure.
- After cleansing and face-wash, an oily pack agent containing 65 mass % of the magnetic powder 11 was applied to the control portion and allowed to leave for 3 minutes. Three minutes later, the
magnet 3 was allowed to approach the oily pack agent applied to theskin 2 and the magnetic powder 11 and the used oily pack agent were attracted and removed from theskin 2. After the attraction and removal, a lotion containing sodium L-ascorbic acid-2-phosphate was applied to the control portion and the iontophoretic current was applied similarly to the treatment portion for about 5 minutes. - Note that, specific compositions of the oily pack agent and lotion applied to the control portion are as follows:
- [Oily Pack Agent]
-
Excipient Triethylhexanoin 21.4 mass % Vaseline 3.5 mass % Magnetic powder 11 65 mass % Surfactant Glyceryl stearate 1.1 mass % Polyglyceryl Laurate-10 0.7 mass % Emulsifier Cetanol 1.8 mass % Sorbitan Stearate 1.8 mass % Lubricant, preservative and others balance - [Lotion]
-
Iontophoretic component 13Sodium L-ascorbic acid-2-phosphate 0.1 mass % Sodium citrate 0.08 mass % Citric acid 0.02 mass % Butylene glycol 5 mass % Glycerin 3 mass % Dipropylene glycol 2 mass % Water, thickener, preservative and etc. balance - <Evaluation>
- At the starting time of the test and the completion time of the test (after a lapse of 4 weeks), skin elasticity was measured by a skin viscoelasticity measuring device (“Cutometer (registered trade mark)”, manufactured by Courage+Khazaka). Measurement was repeated 5 times with respect to each of the treatment portion of the cheek and the control portion of the cheek and 5 measurement values were averaged. Note that, skin elasticity was measured after the measurement sites were acclimated to an environment of temperature of 22±2° C., relative humidity of 50±3% RH by exposing the sites to the environment continuously for 10 minutes.
- Table 1 shows skin elasticity values at the starting time of the test and the completion time of the test, and the difference between the skin elasticity values per subject.
FIG. 3 is a graph showing the average skin elasticity value of the subjects at the starting time of the test and the average skin elasticity value of the subjects at the completion time of the test. The vertical axis inFIG. 3 represents the average skin elasticity value. - As is apparent from Table 1 and
FIG. 3 , the skin elasticity of the treatment portion was improved after the test in almost all subjects. Furthermore, it was demonstrated that skin elasticity tends to be improved with the passage of time. The skin elasticity at the completion time of the test was improved by 14.5% in average, compared to the skin elasticity at the starting time of the test. An increase of the skin elasticity is statistically significant at a 1% level. - In contrast, the skin elasticity of the control portion was improved only in half of the subjects; however, tendency of improving skin elasticity with time was not observed. The skin elasticity at the completion time of the test increased by 0.4% in average, compared to the skin elasticity at the starting time of the test. However, it was not recognized that the increase in skin elasticity value has a statistically significant difference. From the above results, it is found that beauty effect, i.e., improvement of skin elasticity, was obtained by the beauty care method.
-
TABLE 1 Treatment Portion Control Portion After Difference After Difference Test Subject At the Start Completion between Skin At the Start Completion between Skin ID of Test of Test Elasticity Values of Test of Test Elasticity Values 1 0.272 0.340 0.068 0.282 0.278 −0.004 2 0.286 0.298 0.012 0.317 0.272 −0.045 3 0.302 0.320 0.018 0.284 0.292 0.008 4 0.262 0.312 0.050 0.296 0.230 −0.066 5 0.298 0.384 0.086 0.290 0.356 0.066 6 0.290 0.338 0.048 0.284 0.256 −0.028 7 0.268 0.326 0.058 0.246 0.272 0.026 8 0.314 0.306 −0.008 0.288 0.340 0.052 Average Value 0.287 0.328 0.042 0.286 0.287 0.001 - Referring to
FIG. 4 toFIG. 13 , an example of the beauty care instrument to be used in the beauty care method will be described. As shown inFIG. 4 , thebeauty care instrument 7 has a virtually rod-like body portion 71, anattraction head 72 provided at one of the ends of thebody portion 71 and a workingelectrode 41 provided at the other end of thebody portion 71. Theattraction head 72 has a magneticforce generation surface 720 for attracting and removing theaqueous pack agent 1 applied to theskin 2 by the magnetic force, as shown inFIG. 6 andFIG. 7 . As shown inFIG. 13 , thebeauty care instrument 7 is constituted in such a design that an iontophoretic current can be supplied to the contact portion at which the workingelectrode 41 remains in contact with theskin 2. As shown inFIG. 7 , thebody portion 71 houses apower supply section 733 for supplying a power to the workingelectrode 41 and acontrol section 73 for controlling the current to be supplied to the contact portion. - Now, the
beauty care instrument 7 will be more specifically described below. As shown inFIG. 4 toFIG. 6 , thebody portion 71 in thebeauty care instrument 7 has theattraction head 72 and acounter electrode 42, which is constituted in such a design that a circular current pathway can be formed between thepower supply section 733 and a human body, together with the workingelectrode 41, at one end. At the other end, thebody portion 71 has the workingelectrode 41. Note that, hereinafter, in the longitudinal direction of thebody portion 71, a side on which the workingelectrode 41 is provided is sometimes referred to as a front side, and a side on which theattraction head 72 is provided is sometimes referred to as a back side. In addition, when thebeauty care instrument 7 is viewed along the front-back direction, a side on which the magneticforce generation surface 720 is present is sometimes referred to as a lower side, and a side opposite to the lower side is sometimes referred to as an upper side. Further, a direction perpendicular to both the front-back direction and the upper-lower direction is sometimes referred to as a lateral direction. These directional expressions are designated for convenience sake and nothing to do with actual directions of thebeauty care instrument 7 when used. - As shown in
FIG. 4 andFIG. 7 , thebody portion 71 shows a virtually arcuate shape as viewed form the lateral side; more specifically, has a curved shape, in which almost the middle portion in the front-back direction (longitudinal direction) protrudes upwards compared to the both ends. The both ends in the front-back direction of thebody portion 71 each have a virtually arc-like outer shape as viewed in the upper-lower direction, as shown inFIG. 5 andFIG. 6 . Thebody portion 71 is formed such that the middle portion in the longitudinal direction is narrower than the both ends, as viewed in the upper-lower direction. - As shown in
FIG. 4 , theattraction head 72 provided at the back end of thebody portion 71 has a bulgedportion 721 bulging downward from thebody portion 71. The bulgedportion 721 has the magneticforce generation surface 720 at a top surface thereof. - As shown in
FIG. 7 , the bulgedportion 721 has the magneticforce generation surface 720 formed of a flat plane and ahead sidewall 722 extending from the outer peripheral edge of the magneticforce generation surface 720. As shown inFIG. 6 , the magneticforce generation surface 720 has a virtually oval shape as viewed from the lower side and the long axis of the oval is placed along the front-back direction (longitudinal direction). As shown inFIG. 7 , thehead sidewall 722 is formed in such a way that the wall gradually spreads out upwards from the outer peripheral edge of the magneticforce generation surface 720. The magneticforce generation surface 720 and thehead sidewall 722 are connected via a gently curved surface. - As shown in
FIG. 7 , the bulgedportion 721 of theattraction head 72 houses a virtually cylindricalpermanent magnet 723. Thepermanent magnet 723 is disposed in the bulgedportion 721 such that one of the magnetic pole faces comes into contact with the inner wall surface of the magneticforce generation surface 720. The other magnetic pole face of thepermanent magnet 723 is covered with ayoke material 724 made of a soft magnetic material. In this manner, thebeauty care instrument 7 is constituted to more strongly apply the magnetic force generated from thepermanent magnet 723 downward. - Note that, the
permanent magnet 723 of this example is a neodymium magnet magnetized in the axial direction. Since the neodymium magnet is used, the magnetic flux density, which was measured at a point below the magneticforce generation surface 720 having a distance of 20 mm from the center portion of thesurface 720, was 43 mT. - As shown in
FIG. 7 , thebody portion 71 has thecounter electrode 42 at the opposite side (upper side) to the magneticforce generation surface 720. As shown inFIG. 6 , the workingelectrode 41 is disposed such that the electrode surface faces to a side on which the magneticforce generation surface 720 is provided (lower side). The workingelectrode 41 and thecounter electrode 42 are each formed such that the width in the lateral direction is narrower than the maximum width of thebody portion 71. - As shown in
FIG. 7 , thebody portion 71 houses apower supply section 733, acontrol section 73, anLED indicator 713 and avibration motor 714. Thepower supply section 733 is disposed between the center in the longitudinal direction and the workingelectrode 41 in thebody portion 71, and constituted so as to house abattery 733 a in a space within thebody portion 71. As shown inFIG. 6 andFIG. 7 , thebattery 733 a is stored within thebody portion 71 with the help of adetachable lid portion 733 b provided to thebody portion 71. - The
control section 73 is arranged close to theattraction head 72 from the center of thebody portion 71 in the longitudinal direction. As shown inFIG. 5 andFIG. 7 , theLED indicator 713, is arranged at a virtually center of thebody portion 71 in the longitudinal direction. TheLED indicator 713 is constituted to emit light upward when an iontophoretic current flows from the workingelectrode 41 to theskin 2. Thevibration motor 714 is provided within thebody portion 71 at the end close to the workingelectrode 41. Thevibration motor 714 is constituted to be driven when an iontophoretic current flows from the workingelectrode 41 to theskin 2 and generate vibration. - Now, referring to
FIG. 8 , electrical connection between individual sections in thebeauty care instrument 7 will be described. Thepower supply section 733 is connected to each of acontrol microcomputer 730 and avoltage applying section 731 in thecontrol section 73, theLED indicator 713 and thevibration motor 714 and supplies a power for operation to each of these sections. - The
control section 73 has thecontrol microcomputer 730, thevoltage applying section 731 and areflux section 732. Thecontrol section 73 is connected to each of thepower supply section 733, the workingelectrode 41, thecounter electrode 42, theLED indicator 713 and thevibration motor 714 and constituted such that operations of these sections can be controlled. Thecontrol microcomputer 730 has a function of inputting and outputting signals for controlling the operation of each section. Thevoltage applying section 731 has a function of applying a voltage between the workingelectrode 41 and thecounter electrode 42. Thereflux section 732 has a function of taking in the current flowing through a human body from the workingelectrode 41 or thecounter electrode 42 and returning the current to thepower supply section 733. - The
control microcomputer 730 and thevoltage applying section 731 are mutually connected such that a voltage control signal and a current value selection signal described later can be transmitted. Thereflux section 732 is disposed between thevoltage applying section 731 and aground section 731 c, which is connected to the negative pole of thepower supply section 733. Thereflux section 732 is connected to an ADC (Analog to Digital Converter) 730 a as described later of thecontrol microcomputer 730. In this way, thecontrol section 73 is constituted such that the potential difference in thereflux section 732 can be input into thecontrol microcomputer 730. - The
control microcomputer 730 has theADC 730 a, acalculation section 730 b, asignal output section 730 c and adelay timer 730 d. TheADC 730 a has a function of digitalizing the potential difference in thereflux section 732. Thecalculation section 730 b has a function of determining whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body. Thesignal output section 730 c has a function of controlling the current to be supplied from the workingelectrode 41 to askin surface 21 which is desired to produce a beauty effect. - The
ADC 730 a is connected to thereflux section 732 of thecontrol section 73 and constituted to digitalize the potential difference of the potential of thereflux section 732 from the potential of theground section 731 c (hereinafter the potential of theground section 731 c will be referred to as “ground potential”). The potential difference value digitalized by theADC 730 a is sent to thecalculation section 730 b in thecontrol microcomputer 730. - In the
calculation section 730 b, the potential difference value input by theADC 730 a is compared to a predetermined threshold. Thecalculation section 730 b is constituted such that if the potential difference value is less than the predetermined threshold, thecalculation section 730 b determines that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body; whereas, if the potential difference value is the predetermined threshold or more, thecalculation section 730 b determines that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body. Also, thecalculation section 730 b is constituted such that thesection 730 b can control the signal output from thesignal output section 730 c based on both of the determination results and the preset operation flow shown inFIG. 9 andFIG. 10 . Note that, the operation flow is more specifically described later. - The
signal output section 730 c is constituted to receive a control signal from thecalculation section 730 b and then output a voltage control signal and a current value selection signal to thevoltage applying section 731. The voltage control signal is input into apolarity inverting circuit 731 a described later in thevoltage applying section 731 and controls on-off and polarity of the voltage to be applied between the workingelectrode 41 and thecounter electrode 42. The current value selection signal is input into a constantcurrent circuit 731 b described later in thevoltage applying section 731 and controls the value of current flowing between the workingelectrode 41 and thecounter electrode 42. - The
signal output section 730 c is also connected to theLED indicator 713 and thevibration motor 714. Thesignal output section 730 c is constituted such that if thecalculation section 730 b determines that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body, thesignal output section 730 c outputs individual signals for emitting theLED indicator 713 and driving thevibration motor 714. - The
delay timer 730 d is driven by thecalculation section 730 b if thecalculation section 730 b determines that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body. Thedelay timer 730 d has a function of stopping operation of thecalculation section 730 b for a predetermined time. Owing to the function, in thebeauty care instrument 7, operations of individual sections are stopped in accordance with the stop in operation of thecalculation section 730 b for the predetermined time from the starting up of thedelay timer 730 d. Thedelay timer 730 d is constituted to restart thecalculation section 730 b after the passage of the predetermined time. - The
voltage applying section 731 has thepolarity inverting circuit 731 a and the constantcurrent circuit 731 b, which are mutually connected. Thepolarity inverting circuit 731 a and thesignal output section 730 c of thecontrol microcomputer 730 are mutually connected. Thepolarity inverting circuit 731 a is connected to each of the workingelectrode 41 and thecounter electrode 42. Accordingly, thepolarity inverting circuit 731 a is constituted such that the potential difference between the workingelectrode 41 and thecounter electrode 42 can be controlled based on the voltage control signal output from thesignal output section 730 c. - The constant
current circuit 731 b has a function of maintaining the current flowing between the workingelectrode 41 and thecounter electrode 42 to be constant. The constantcurrent circuit 731 b and thesignal output section 730 c of thecontrol microcomputer 730 are mutually connected. The constantcurrent circuit 731 b is constituted such that the current flowing between the workingelectrode 41 and thecounter electrode 42 can be set at two levels, based on the current value selection signal output from thesignal output section 730 c. In this example, the current value of the current is set at two levels: iontophoresis level and skin care level, which is lower than the iontophoresis level. Note that, the iontophoresis level is applied during the operations in iontophoresis step S8 and reset pulse step S9; whereas, the skin care level is applied during the operation of skin care step S11. - The
reflux section 732 has aresistor 732 a connected between thevoltage applying section 731 and theground section 731 c. Owing to this, the current taken from thevoltage applying section 731 flows through theresistor 732 a toward theground section 731 c and passes through theground section 731 c to the negative pole of thepower supply section 733. A point between thevoltage applying section 731 andresistor 732 a in thereflux section 732 is connected to theADC 730 a of thecontrol microcomputer 730. Owing to this, theADC 730 a is constituted such that the potential difference between the potential of a point between thevoltage applying section 731 and theresistor 732 a and the ground potential is input. - Now, referring to
FIG. 9 andFIG. 10 , the operational flow of thebeauty care instrument 7 will be described. When a power is supplied to thebeauty care instrument 7 from thepower supply section 733, an initialization of thecontrol microcomputer 730 is carried out (step S1). At this time, thecontrol microcomputer 730 outputs a current value selection signal to the constantcurrent circuit 731 b to set the current value at the iontophoresis level. - Thereafter, the
control microcomputer 730 turns on thedelay timer 730 d and executes step S2 of waiting the elapse of the predetermined time. Note that the predetermined time can be appropriately set within the range of 50 to 1000 milliseconds by thedelay timer 730 d of this example. - Following step S2, the
control microcomputer 730 executes step S3 for supplying the power for operation from thepower supply section 733 to thevoltage applying section 731; at the same time, a voltage control signal is output from thesignal output section 730 c. Owing to the operation, while thecontrol microcomputer 730 controls the potential difference between two electrodes such that the potential of the workingelectrode 41 is lower than that of thecounter electrode 42 and applies a pulse voltage once between the two electrodes. In this manner, step S4 of applying a pulse voltage once between the workingelectrode 41 and thecounter electrode 42 is carried out. In this example, the value of the pulse voltage in step S4 was specified to be 5V. - Subsequently, as shown in
FIG. 9 , step S5 of measuring the potential difference in thereflux section 732 is carried out. In step S5, when the workingelectrode 41 and thecounter electrode 42 are both in contact with theskin 2, a pulse current ascribed to the pulse voltage flows from thecounter electrode 42 to the workingelectrode 41 via a human body. The pulse current is taken from the workingelectrode 41 into thecontrol section 73 and produces the potential difference between both ends ofresistor 732 a in thereflux section 732, like waveform F4 shown inFIG. 11 . The potential difference produced between the both ends of theresistor 732 a, in other words, the potential difference of thereflux section 732 from the ground potential is input into theADC 730 a of thecontrol microcomputer 730 and the value is measured. - In contrast, when at least one of the working
electrode 41 and thecounter electrode 42 is not in contact with theskin 2, even if the pulse voltage is applied, no current flows through theresistor 732 a, with the result that no potential difference is produced between the both ends of theresistor 732 a. Because of this, when at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with theskin 2, the value of the potential difference becomes 0 V. - Thereafter, the
control microcomputer 730 executes step S6 of determining whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body based on the results of comparison between the potential difference and a predetermined threshold L (see,FIG. 11 ) in thecalculation section 730 b. If the potential difference obtained in step S5 is less than threshold L, thecontrol microcomputer 730 determines that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body (“No” in Step S6). In this case, thecontrol microcomputer 730 instructs to go back to step S2 of driving thedelay timer 730 d. Thecontrol microcomputer 730 executes step S2 to step S6 repeatedly as long as it is determined that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body in step S6. Note that, in this example, threshold L can be appropriately set between 50 to 200 mV. - In contrast, as shown in
FIG. 11 , if the potential difference of thereflux section 732 from the ground potential is threshold L or more in step S6, thecontrol microcomputer 730 determines that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body (“Yes” in step S6). In this case, as shown inFIG. 9 , thecontrol microcomputer 730 executes step S7 of inputting a current value selection signal into the constantcurrent circuit 731 b to set the current value at the iontophoresis level. Following step S7, thecontrol microcomputer 730 sends a voltage control signal, which instructs to supply an iontophoretic current from the workingelectrode 41 to theskin 2, to thevoltage applying section 731. - As shown in
FIG. 9 , the iontophoretic current is constituted to sequential repeats of iontophoresis step S8 of supplying a single-polarity current to a portion at which the workingelectrode 41 is in contact with the skin 2 (F1,FIG. 2 ); reset pulse step S9 of supplying a pulse current of the other polarity to the contact portion (F2,FIG. 2 ); and skin care step S11 of supplying a current in which polarity alternately changes to the contact portion (F3,FIG. 2 ). In this procedure, the waveform of the iontophoretic current flowing through theskin 2 is constituted of repeats of basic waveforms F1 to F3 as shown inFIG. 2 . - The
control microcomputer 730 outputs a drive signal from thesignal output section 730 c to theLED indicator 713 and thevibration motor 714 as long as the iontophoretic current flows through the skin 2 (step T1,FIG. 10 ). Owing to this, theLED indicator 713 and thevibration motor 714 are driven as long as the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body. - To describe more specifically, in iontophoresis step S8, the
control microcomputer 730 controls the potential difference between two electrodes such that the potential of the workingelectrode 41 is lower than the potential of thecounter electrode 42; at the same time, a pulse voltage is applied between the two electrodes in plurality of times. Owing to this, the workingelectrode 41 can supply a negative-polarity pulse current like the basic waveform F1 shown inFIG. 2 to theskin 2, a plurality of times. - In reset pulse step S9, the
control microcomputer 730 controls the potential difference between two electrodes such that the potential of the workingelectrode 41 is higher than the potential of thecounter electrode 42; at the same time, a pulse voltage is once applied between the two electrodes. Owing to this, the workingelectrode 41 can supply a positive-polarity pulse current like the basic waveform F2 shown inFIG. 2 to theskin 2. - Following reset pulse step S9, the
control microcomputer 730 executes step S10 of outputting a current value selection signal to the constantcurrent circuit 731 b to set a current value at the skin care level, as shown inFIG. 9 . - Following step S10, the
control microcomputer 730 executes skin care step S11, as shown inFIG. 9 . In skin care step S11, thecontrol microcomputer 730 applies a square wave, in which the high and low of potential difference of the workingelectrode 41 to thecounter electrode 42 alternately changes, to the two electrodes. Owing to this, the workingelectrode 41 can supply a square wave current, in which a positive polarity and a negative polarity alternately change like basic waveform F3 shown inFIG. 2 to theskin 2. - As shown in
FIG. 10 , thecontrol microcomputer 730 has a skin detecting function, which carries out determination as to whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body by use of the pulse of an iontophoretic current flowing through theskin 2, in parallel to step S7 to S11. In other words, thecontrol microcomputer 730 is constituted such that step T2 of measuring the potential difference of the reflux section 732 (produced due to the pulse current) from the ground potential is carried out by using the pulse current flowing through theskin 2 in iontophoresis step S8, reset pulse step S9 and skin care step S11, similarly to step S5. - As shown in
FIG. 10 , thecontrol microcomputer 730 executes step T3 of determining the contact state whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body based on the results of measuring the potential difference of thereflux section 732. The determination in step T3 as to the contact state whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body may be made based on the measurement result of potential difference from a single pulse current, or total of measurement results of potential differences from a plurality of pulse currents. Furthermore, the pulse current to be used in determination of the contact state can be appropriately selected from the pulse currents in iontophoresis step S8, reset pulse step S9 and skin care step S11. - In this example, for example, the determination of the contact state in step T3 is made based on the determination whether or not the potential difference values between both ends of the
resistor 732 a due to a pulse current (F2,FIG. 2 ) in reset pulse step S9 are continuously lower than threshold L, at predetermined number of times. In other words, if the potential difference values due to a pulse current (F2,FIG. 2 ) are continuously less than threshold L (“Yes”, step T3,) at predetermined number of times, thecontrol microcomputer 730 of this example determines that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body. In this case, thecontrol microcomputer 730 terminates supply of the iontophoretic current and simultaneously terminates output of a drive signal to theLED indicator 713 and the vibration motor 714 (step T4). Thecontrol microcomputer 730 is constituted to repeat step S2 to step S6 (shown inFIG. 9 ) after step T4. - In contrast, as long as the number of cases where the potential difference values are continuously less than threshold L, does not reach predetermined number of times (“No”, step T3), the
control microcomputer 730 determines that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body. As long as thecontrol microcomputer 730 determines that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body in step T3, thecontrol microcomputer 730 repeatedly executes step S7 to step S11 shown inFIG. 9 . - Next, how to use the
beauty care instrument 7 will be described. - After the user applies the
aqueous pack agent 1, the user holds thebody portion 71 at the side of the workingelectrode 41 and makes the magneticforce generation surface 720 of theattraction head 72 closer to theskin 2, as shown inFIG. 12 . In this case, a detachable cover member may be provided to the magneticforce generation surface 720 in advance. The shape, material and others of the cover member are not particularly limited as long as the member can cover the magneticforce generation surface 720 and any type of cover member may be used. In this example, theattraction head 72 is wrapped with cotton sheet (not shown in the figure). - By this operation, dirt 200 of the
skin 2 and others is removed together with the magnetic powder 11 from theskin surface 21 and attracted by theattraction head 72, as mentioned above. After theaqueous pack agent 1 removed from theskin surface 21, theaqueous solution 12 containing theiontophoretic component 13 remains applied on theskin 2. Note that, the usedaqueous pack agent 1 attracted by theattraction head 72 can be removed together with the cover member from the magneticforce generation surface 720 and discarded. - After the used aqueous pack agent 100 and others are removed from the
skin 2, as mentioned above, the user shifts the position of thebody portion 71 to be held such that the workingelectrode 41 protrudes from the hand and thecounter electrode 42 comes into contact with the hand. Then, the workingelectrode 41 is allowed to touch theskin surface 21, as shown inFIG. 13 . Owing to the operation, through the contact portion of the workingelectrode 41 in contact with theskin 2, the iontophoretic current, which consists of repeats of basic waveform F1 to F3 shown inFIG. 2 , flows. Note that, in this example, in iontophoresis step S8, the workingelectrode 41 serves as a cathode; whereas, thecounter electrode 42 serves as an anode, and a negative-polarity current flows to theskin surface 21 in contact with the workingelectrode 41. In this manner, thebeauty care instrument 7 allows L-ascorbic acid 2-phosphate ion 131 (anion) to infiltrate into the skin. - Now, the effect of the
beauty care instrument 7 will be described. Thebeauty care instrument 7 has theattraction head 72 for attracting and removing theaqueous pack agent 1 by the magnetic force. Owing to this, as shown inFIG. 12 , when the user holds thebody portion 71 and approaches theattraction head 72 to theskin surface 21 to which theaqueous pack agent 1 is applied, theaqueous pack agent 1 is attracted by theattraction head 72 with the help of the magnetic force. As a result, thebeauty care instrument 7 can easily remove the usedaqueous pack agent 1. - As shown in
FIG. 4 , thebeauty care instrument 7 has the workingelectrode 41 for supplying an iontophoretic current to the contact portion while theelectrode 41 remains in contact with theskin 2. Accordingly, when the user brings the workingelectrode 41 into contact with theskin 2 to which a charged beauty component is previously applied, and then an iontophoretic current is supplied, as mentioned above, the beauty component easily migrates into the skin. As a result, thebeauty care instrument 7 facilitates infiltration of the beauty component and easily and immediately exerts a beauty effect. - The
beauty care instrument 7 has both theattraction head 72 and the workingelectrode 41. Accordingly, as mentioned above, a working step of removing dirt of theskin 2 and waste with theaqueous pack agent 1 and a working step of allowing a charged beauty component to infiltrate into the skin by an iontophoretic current can be carried out by using one instrument. As a result, it is not necessary for the user to individually prepare instruments for the two working steps and select the instrument depending upon the use. - As shown in
FIG. 4 , theattraction head 72 has the magneticforce generation surface 720 facing in the direction in virtually perpendicular to the longitudinal direction of the body portion 71 (down side). Accordingly, it is easy for the user to face the magneticforce generation surface 720 towards theskin 2 to which theaqueous pack agent 1 is applied just by holding thebody portion 71, as shown inFIG. 12 . As a result, the user can extremely conveniently use thebeauty care instrument 7. - As shown in
FIG. 7 , thebody portion 71 has thecounter electrode 42 on the opposite (upper) side of the magneticforce generation surface 720, and the workingelectrode 41, which is arranged so as to face down, as shown inFIG. 6 . Accordingly, when the user puts thebeauty care instrument 7 on a table or the like, the possibility of electrical conduction between the workingelectrode 41 and thecounter electrode 42 via the surface of the table can be reduced, as mentioned above, with the result that the power consumption of thebeauty care instrument 7 tends to be reduced. In addition, since a circular current pathway is formed between thepower supply section 733 and a human body, thebeauty care instrument 7 can more efficiently supply an iontophoretic current to the human body. As a result, thebeauty care instrument 7 can further improve a beauty effect. - As shown in
FIG. 8 andFIG. 9 , thecontrol section 73 has a means for applying a pulse voltage to the workingelectrode 41 to measure an electrical characteristic value within thecontrol section 73 based on the pulse voltage, a means for determining whether the workingelectrode 41 and thecounter electrode 42 are in contact with a human body based on the electrical characteristic value, and a means for supplying an iontophoretic current to the contact portion if the workingelectrode 41 and thecounter electrode 42 are determined to be both in contact with a human body; and constituted such that if it is determined that at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body, after the passage of a predetermined time measured by thedelay timer 730 d, measurement of the electrical characteristic value and determination are repeated again. - Accordingly, the
beauty care instrument 7 can supply an iontophoretic current to the contact portion at the time when the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body, without turning on/off a switch. Owing to this, the user can obtain the effect of facilitating infiltration of a beauty component simply by holding thebody portion 71 at the side of thecounter electrode 42 and touching thecounter electrode 42 with a hand; and simultaneously bringing the workingelectrode 41 into contact with a portion at which a beauty effect is desired. - The
beauty care instrument 7 can reduce a frequency of measurement of the electrical characteristic value and the determination as mentioned above by operating thedelay timer 730 d in the aforementioned manner. As a result, in thebeauty care instrument 7, power consumption in the standby state, in other words, in the state where at least one of the workingelectrode 41 and thecounter electrode 42 is not in contact with a human body, can be reduced. - As shown in
FIG. 8 andFIG. 9 , thecontrol section 73 has, thereflux section 732, which takes in the current flowing through a human body and sends the current to thepower supply section 733; and is constituted such that the potential difference of thereflux section 732 from the ground potential is measured as an electrical characteristic value and if the potential difference is a predetermined threshold or more, it is determined that the workingelectrode 41 and thecounter electrode 42 are both in contact with a human body. Accordingly, the circuit design of thecontrol section 73 can be easily simplified, as mentioned above; at the same time, the accuracy in determining that the workingelectrode 41 and thecounter electrode 42 are in contact with a human body can be improved. - As shown in
FIG. 2 andFIG. 9 , the iontophoretic current is constituted of sequential repeats of iontophoresis step S8 of supplying a single-polarity current (FIG. 2 , F1) to the contact portion; reset pulse step S9 of supplying a pulse current (FIG. 2 , F2) having the other polarity to the contact portion; and skin care step S11 of supplying current (FIG. 2 , F3), in which polarity alternately changes, to the contact portion. Accordingly, as mentioned above, it is expected that the beauty effect can be further improved by thebeauty care instrument 7 since an effect of facilitating infiltration of a beauty component into the skin and an effect of activating theskin 2 are synergetically exerted. - The
beauty care instrument 7 has thevibration motor 714 at the edge close to the workingelectrode 41 and constituted such that thevibration motor 714 is driven while an iontophoretic current flows through theskin 2. Thus, owing to vibration generated from thevibration motor 714, effects such as a lymph-flow improvement effect, a blood-circulation improvement effect and a metabolism improving effect, may be obtained in the portion at which the workingelectrode 41 is in contact with theskin 2 and the portion around them. As a result, thebeauty care instrument 7 can contribute to further improvement of the beauty effect that the user feels. - As described in the foregoing, the
beauty care instrument 7 successfully improves convenience in continuously carrying out a work step of removing dirt of skin and waste and a work step of allowing a beauty component to infiltrate into the skin. - Note that, Example 2 shows an example of the
beauty care instrument 7 having theattraction head 72 for attracting and removing the magnetic powder 11 by the magnetic force and also constituted as an iontophoretic instrument for supplying an iontophoretic current to theskin 2. However, a work step of attracting the magnetic powder 11 and an iontophoretic step can be carried out by using different instruments. For example, as shown inFIG. 14 andFIG. 15 , a work step of attracting the magnetic powder 11 can be carried out by thebeauty care instrument 7 b having theattraction head 72 alone without providing e.g. the workingelectrode 41 or thecontrol section 73. Note that, of the reference numerals used inFIG. 14 andFIG. 15 , the same reference numerals used in Example 2 designate the same structural elements corresponding to those used in Example 2. - As is not shown in the figures, for example, iontophoresis can be carried out by the
beauty care instrument 7 having e.g., the workingelectrode 41 and thecontrol section 73 without providing theattraction head 72. The shape of thebeauty care instrument 7 is not limited to that shown in Example 2 and can be variously modified. For example, thebody portion 71 may have a spherical or cylindrical shape.
Claims (12)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013266211 | 2013-12-25 | ||
JP2013-266211 | 2013-12-25 | ||
JP2014023921A JP6522281B2 (en) | 2013-12-25 | 2014-02-11 | Operating method of beauty device |
JP2014-023921 | 2014-02-11 | ||
PCT/JP2014/079275 WO2015098295A1 (en) | 2013-12-25 | 2014-11-04 | Cosmetic method |
Publications (2)
Publication Number | Publication Date |
---|---|
US20180193238A1 true US20180193238A1 (en) | 2018-07-12 |
US10548822B2 US10548822B2 (en) | 2020-02-04 |
Family
ID=53478173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/106,933 Active 2036-07-03 US10548822B2 (en) | 2013-12-25 | 2014-11-04 | Beauty care method |
Country Status (11)
Country | Link |
---|---|
US (1) | US10548822B2 (en) |
EP (1) | EP3088042A4 (en) |
JP (1) | JP6522281B2 (en) |
KR (1) | KR20160103049A (en) |
CN (1) | CN106102824B (en) |
AU (1) | AU2014371743A1 (en) |
CA (1) | CA2932852A1 (en) |
RU (1) | RU2677920C2 (en) |
SG (2) | SG11201604439UA (en) |
TW (1) | TW201531260A (en) |
WO (1) | WO2015098295A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3075374A4 (en) * | 2013-11-29 | 2017-05-03 | MTG Co., Ltd. | Water-based skin care agent |
CN106310515B (en) * | 2016-08-31 | 2018-10-23 | 广州风速信息技术有限公司 | Intelligent beautifying face device |
CN111789772A (en) * | 2019-04-08 | 2020-10-20 | 美帕信息科技(上海)有限公司 | Magnetic facial mask with supplementary use of magnetic rod |
JP2021132691A (en) * | 2020-02-21 | 2021-09-13 | パナソニックIpマネジメント株式会社 | Cosmetic component spraying device |
JP7411896B2 (en) * | 2020-02-21 | 2024-01-12 | パナソニックIpマネジメント株式会社 | Beauty ingredient spray device |
JPWO2022191146A1 (en) * | 2021-03-11 | 2022-09-15 | ||
KR102537208B1 (en) * | 2021-04-26 | 2023-05-26 | 이성화 | A lifting cosmetic composition comprising magnetic particle |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030073022A1 (en) * | 2001-09-28 | 2003-04-17 | Lars Hultman | Electrophotographic carrier core magnetite powder |
JP2004155720A (en) * | 2002-11-07 | 2004-06-03 | Masachika Hattori | Pack preparation |
JP2004224782A (en) * | 2003-01-22 | 2004-08-12 | Yukipuramu Company:Kk | Cosmetic containing magnetic material powder |
US20070148112A1 (en) * | 2005-12-28 | 2007-06-28 | Avon Products, Inc. | Foaming, color-changing topical composition and method of imparting a cosmetic effect |
WO2007104089A1 (en) * | 2006-03-10 | 2007-09-20 | Annum 21 Pty Limited | Composition |
JP4768404B2 (en) * | 2005-11-08 | 2011-09-07 | 株式会社 資生堂 | Beauty method by iontophoresis |
US20120271219A1 (en) * | 2011-04-19 | 2012-10-25 | David John Weisgerber | Combined Energy and Topical Composition Application For Regulating the Condition of Mammalian Skin |
US20130315846A1 (en) * | 2012-05-22 | 2013-11-28 | Mary Kay Inc. | Cosmetic compositions |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1051737A (en) | 1974-04-23 | 1979-04-03 | Rene Laguerre | Method, product and apparatus for cleaning the cuticle |
JPS613765A (en) | 1984-06-18 | 1986-01-09 | Konishiroku Photo Ind Co Ltd | Thermal transfer printer |
JPS6468313A (en) * | 1987-09-09 | 1989-03-14 | Hitachi Metals Ltd | Magnetic cream for cleaning cuticle |
RU2147430C1 (en) * | 1998-08-18 | 2000-04-20 | Закрытое акционерное общество научно-производственная фирма "Новь" | Cosmetic mask (variants) |
JP2003199620A (en) * | 2001-12-28 | 2003-07-15 | Masachika Hattori | Beautification system |
JP4263904B2 (en) * | 2002-12-10 | 2009-05-13 | 有限会社相和エンジニアリング | Method of removing iron powder from magnet remover and iron powder cream for beautiful skin |
US20070009560A1 (en) | 2003-09-30 | 2007-01-11 | Coty B.V. | Cosmetic and dermatological agent containing magnetic particles production thereof and use of the same |
JP2005239563A (en) * | 2004-02-24 | 2005-09-08 | Nissei Kosan Kk | Composition for skin application |
JP4460348B2 (en) * | 2004-04-27 | 2010-05-12 | 優親 服部 | Pack remover |
WO2006131997A1 (en) * | 2005-06-07 | 2006-12-14 | Ya-Man Ltd. | Treatment device |
US20070148105A1 (en) | 2005-12-22 | 2007-06-28 | Donald Spector | Compositions and methods comprising magnetic particles for health use |
US20070292463A1 (en) | 2005-12-22 | 2007-12-20 | Donald Spector | Compositions and methods comprising energizable particles for health use |
CN101357105A (en) * | 2007-08-02 | 2009-02-04 | 罗云 | Magnetic far-infrared negative-ion energy eye-mask |
ITMI20072098A1 (en) * | 2007-10-30 | 2009-04-30 | Dermophisiologique S R L | A COSMETIC COMPOSITION BASED ON A MAGNETIC OR MAGNETIZABLE MATERIAL, ITS PREPARATION AND ITS USE FOR CLEANING THE EPIDERMIDAL |
KR101194560B1 (en) | 2010-03-18 | 2012-10-31 | 이용식 | Cosmetic container with massage device attached to the lower part using magnet |
JP2013001685A (en) * | 2011-06-17 | 2013-01-07 | Epia:Kk | Iron powder-containing cosmetic cream, and stick for the same |
EP3075374A4 (en) * | 2013-11-29 | 2017-05-03 | MTG Co., Ltd. | Water-based skin care agent |
-
2014
- 2014-02-11 JP JP2014023921A patent/JP6522281B2/en active Active
- 2014-11-04 US US15/106,933 patent/US10548822B2/en active Active
- 2014-11-04 SG SG11201604439UA patent/SG11201604439UA/en unknown
- 2014-11-04 EP EP14875841.0A patent/EP3088042A4/en not_active Withdrawn
- 2014-11-04 CN CN201480071088.4A patent/CN106102824B/en not_active Expired - Fee Related
- 2014-11-04 AU AU2014371743A patent/AU2014371743A1/en not_active Abandoned
- 2014-11-04 KR KR1020167020002A patent/KR20160103049A/en not_active Application Discontinuation
- 2014-11-04 CA CA2932852A patent/CA2932852A1/en not_active Abandoned
- 2014-11-04 RU RU2016130042A patent/RU2677920C2/en not_active IP Right Cessation
- 2014-11-04 SG SG10201804768VA patent/SG10201804768VA/en unknown
- 2014-11-04 WO PCT/JP2014/079275 patent/WO2015098295A1/en active Application Filing
- 2014-11-10 TW TW103138909A patent/TW201531260A/en unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030073022A1 (en) * | 2001-09-28 | 2003-04-17 | Lars Hultman | Electrophotographic carrier core magnetite powder |
JP2004155720A (en) * | 2002-11-07 | 2004-06-03 | Masachika Hattori | Pack preparation |
JP2004224782A (en) * | 2003-01-22 | 2004-08-12 | Yukipuramu Company:Kk | Cosmetic containing magnetic material powder |
JP4768404B2 (en) * | 2005-11-08 | 2011-09-07 | 株式会社 資生堂 | Beauty method by iontophoresis |
US20070148112A1 (en) * | 2005-12-28 | 2007-06-28 | Avon Products, Inc. | Foaming, color-changing topical composition and method of imparting a cosmetic effect |
WO2007104089A1 (en) * | 2006-03-10 | 2007-09-20 | Annum 21 Pty Limited | Composition |
US20120271219A1 (en) * | 2011-04-19 | 2012-10-25 | David John Weisgerber | Combined Energy and Topical Composition Application For Regulating the Condition of Mammalian Skin |
US20130315846A1 (en) * | 2012-05-22 | 2013-11-28 | Mary Kay Inc. | Cosmetic compositions |
Also Published As
Publication number | Publication date |
---|---|
RU2016130042A (en) | 2018-01-30 |
SG11201604439UA (en) | 2016-07-28 |
TW201531260A (en) | 2015-08-16 |
AU2014371743A1 (en) | 2016-06-23 |
EP3088042A4 (en) | 2017-12-27 |
RU2016130042A3 (en) | 2018-05-31 |
JP2015142698A (en) | 2015-08-06 |
CN106102824A (en) | 2016-11-09 |
EP3088042A1 (en) | 2016-11-02 |
JP6522281B2 (en) | 2019-05-29 |
SG10201804768VA (en) | 2018-07-30 |
CA2932852A1 (en) | 2015-07-02 |
WO2015098295A1 (en) | 2015-07-02 |
RU2677920C2 (en) | 2019-01-22 |
US10548822B2 (en) | 2020-02-04 |
CN106102824B (en) | 2019-09-27 |
KR20160103049A (en) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10548822B2 (en) | Beauty care method | |
JP6490200B2 (en) | Skin care product and skin care method | |
JP2020512070A (en) | Skin care applicator | |
JP6824879B2 (en) | Skin care products | |
US10932997B2 (en) | Aqueous skin care agent | |
JP2011507630A (en) | Magnetically assisted therapeutic delivery method and system | |
JP6391250B2 (en) | Two-component mixed skin care agent and magnetic powder-containing agent and liquid agent used therefor | |
JP6270462B2 (en) | Skin care agent | |
WO2019033376A1 (en) | Skin care products | |
CN107822941A (en) | Beauty and skin care agent | |
JP2015016292A (en) | Remover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MTG CO., LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MATSUSHITA, TSUYOSHI;REEL/FRAME:038973/0199 Effective date: 20160525 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |